Sana biotechnology announces the appointment of two pioneers in drug discovery and development to lead its r&d organization

Dr. douglas e. williams as head of research and development dr. gary meininger as chief medical officer seattle, april 10, 2023 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on changing the possible for patients through engineered cells, today announced the appointments of two senior leaders to its research and development organization, douglas e.
SANA Ratings Summary
SANA Quant Ranking